Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • Mona Aarenstrup Karlsen
  • Noreen Sandhu
  • Høgdall, Claus Kim
  • Ib Jarle Christensen
  • Lotte Nedergaard
  • Lene Lundvall
  • Svend A Engelholm
  • Pedersen, Anette Tønnes
  • Dorthe Hartwell
  • Magnus Christian Lydolph
  • Inga Alice Laursen
  • Estrid V S Høgdall
Diagnostic factors are needed to improve the currently used serum CA125 and risk of malignancy index (RMI) in differentiating ovarian cancer (OC) from other pelvic masses, thereby achieving precise and fast referral to a tertiary center and correct selection for further diagnostics. The aim was to evaluate serum Human Epididymis protein 4 (HE4) and the risk of ovarian malignancy algorithm (ROMA) for these purposes.
OriginalsprogEngelsk
TidsskriftGynecologic Oncology
Vol/bind127
Udgave nummer2
Sider (fra-til)379-83
Antal sider5
ISSN0090-8258
DOI
StatusUdgivet - 2012

ID: 48443576